98%
921
2 minutes
20
. Conventional functional connectivity (FC) analysis of wide-field calcium imaging (WFCI) data relies on the assumption of homogeneity within predefined anatomical functional areas (FAs), where the signal averaged within each FA serves as the foundation for inter-FA connectivity modeling. However, accumulating evidence suggested significant intra-FA functional heterogeneity with functionally distinct subregions. This study aims to systematically examine the existence of the heterogeneity and the consequences of violating the homogeneity assumption on the FC analysis.. We propose a three-step approach: (1) The spatiotemporal clustering of pixels with similar activity dynamics into functional parcels (FPs). (2) Classifying FPs according to their cortex-wide connectivity profiles into four categories: cross-hemispheric (CH), unihemispheric (UH), cross-modal (CM) and unimodal (UM). (3) Gauging the consequences and utility of above analysis.. Analysis of adult mice WFCI data (= 6) shows that pixels can be reliably clustered into FPs, and that FPs fall into different categories and form distinct subregions, unveiling the functional heterogeneity within each FA. Crucially, fine-grained FC analysis for different categories of subregions uncovered significant differences compared to the results from the conventional method. Application of the analysis to longitudinal WFCI data on mouse brain development (= 17) demonstrates increases in CM and CH subregions and decreases in UM and UH subregions over time, in line with expectations based on prior research into neurodevelopment and network reorganization.. The present study develops a fine-grained FC analysis framework, leveraging the high spatiotemporal resolution of WFCI to more precisely characterize large-scale cortical network dynamics. The observed differences between FCs derived using the proposed framework and those from conventional methods highlight the need for caution regarding the functional homogeneity assumption in conventional FC analysis. Furthermore, the developmental regularities revealed in longitudinal mouse brain data demonstrate the utility of fine-grained FC analysis.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1088/1741-2552/adff39 | DOI Listing |
J Alzheimers Dis
September 2025
Department of Medicine and Surgery, Unit of Neurology, Neurophysiology, Neurobiology and Psychiatry, Università Campus Bio-Medico di Roma, Roma, Italy.
BackgroundAlzheimer's disease (AD) is the most common neurodegenerative disorder. While AD diagnosis traditionally relies on clinical criteria, recent trends favor a precise biological definition. Existing biomarkers efficiently detect AD pathology but inadequately reflect the extent of cognitive impairment or disease heterogeneity.
View Article and Find Full Text PDFJ Nephrol
September 2025
Department of Psychology, Institute of Psychiatry, Psychology & Neuroscience, Health Psychology Section, King's College London, 5th Floor Bermondsey Wing, Guy's Campus, London Bridge, London, SE1 9RT, UK.
Background: Depression and anxiety are common in chronic kidney disease (CKD) and worsen clinical outcomes. Psycho-behavioural interventions offer a promising, non-pharmacological approach. However, most evidence comes from people with kidney failure with distinct treatment needs, limiting relevance to earlier stages of CKD, where timely support may enhance self-management and slow progression.
View Article and Find Full Text PDFMol Biol Rep
September 2025
Cytogenetics and Molecular Genetics Lab, Pathology Unit, Medical Division (BARC Hospital), Bhabha Atomic Research Centre, Anushakti Nagar, Mumbai, India.
Background: Hearing loss (HL) is one of the most common congenital anomalies and is a complex etiologically diverse condition. Molecular genetic characterization of HL remains challenging owing to the high genetic heterogeneity. This study aimed to screen for potential disease-causing genetic variations in a cohort of Indian patients with congenital bilateral severe-to-profound sensorineural HL.
View Article and Find Full Text PDFBiomater Sci
September 2025
Department of Pharmaceutics and Pharmaceutical Technology, College of Pharmacy, University of Sharjah, Sharjah 27272, United Arab Emirates.
Colorectal cancer (CRC) remains a major global health burden, necessitating more effective and selective therapeutic approaches. Nanocarrier-based drug delivery systems offer significant advantages by enhancing drug accumulation in tumors, reducing off-target toxicity, and overcoming resistance mechanisms. This review provides a comprehensive overview of recent advancements in nanocarriers for CRC therapy, including passive targeting the enhanced permeability and retention (EPR) effect, and active targeting strategies that exploit specific tumor markers using ligands such as antibodies, peptides, and aptamers.
View Article and Find Full Text PDFCancer Immunol Res
September 2025
Alligator Bioscience (Sweden), Lund, Sweden.
Despite recent progress within the field of immuno-oncology, immune suppression in the tumor microenvironment, defective antigen presentation, and low levels of tumor-specific T cells are key limitations of current cancer immunotherapies. CD40-targeting immunotherapies hold promises for addressing these limitations across solid tumors. Here, we describe ATOR-4066, a bispecific antibody that targets CD40 and CEACAM5 developed for immunotherapy of cancer using the Neo-X-Prime platform.
View Article and Find Full Text PDF